Back to search results

Testing the BREASTChoice Tool for Breast Reconstruction Decisions

This study is testing a new version of an online tool called BREASTChoice, designed to help people make informed decisions about breast reconstruction after breast cancer surgery. The goal is to make sure the tool is easy to use and understand, especially on mobile devices. Researchers will observe 20 participants using the tool and ask them questions about their experience. They will also measure how much participants learn about breast reconstruction before and after using the tool. This study is for people aged 18 or older who have had breast surgery (mastectomy or lumpectomy) within the last 8 years and can read and speak English. The study aims to improve the tool so more people can access helpful information about breast reconstruction.

Study design
This is an interventional study with 20 participants. It focuses on testing the usability of the BREASTChoice tool.
What's involved
You would complete a baseline questionnaire, participate in a semi-structured interview while using the BREASTChoice tool, and then complete a post-survey.
Compensation
Not stated in the trial record.
Follow-up
Your breast reconstruction knowledge will be measured up to 1 week after using the tool.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07396766

Dissemination of BREASTChoice AIM1-B

Recruiting
NAAges 18+InterventionalHealth services
UNC Lineberger Comprehensive Cancer Center
~20 participants
Updated 2026-02-09 on ClinicalTrials.gov
What's tested:Baseline QuestionnaireSemi structured InterviewPost Survey

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in breast reconstruction knowledge
Measured over Up to1 week

Conditions

Breast Cancer
Breast Neoplasms

Explore related trials

Breast CarcinomaBreast Ductal Carcinoma In Situ

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Clara Lee · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center

Who to contact

Victoria Triana
[email protected]
919-966-4320
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years at the time of consent
Able to read and speak English.
Have had surgery, such as a mastectomy or lumpectomy, to remove some or all of their breast or breasts.
Breast surgery occurred within the past 8 years.
Breast surgery was due to a diagnosis of breast cancer, ductal carcinoma in situ, or risk of future breast cancer, by participant report.
Sex was assigned "Female" at birth

What this trial measures

  • Change in breast reconstruction knowledgeUp to1 week

    This is knowledge based patient-reported outcome measure uses the Breast Cancer Reconstruction Decision Quality Instrument (DQI). DQ is a 9-item patient-reported measure designed to assess how well patients are informed about breast reconstruction options following breast cancer treatment. The instrument consists of multiple-choice questions with factual, correct answers related to breast reconstruction. Decision quality is quantified as a knowledge score, reflecting the extent to which patients understand key information necessary to make informed reconstruction decisions. Scores range from 0% to 100%. The total score is calculated by summing the number of correctly answered items and dividing by the total number of questions (9), with higher scores indicating greater knowledge and higher decision quality.